Sophie Fawson

Sophie Fawson

Auto-generated profile, based on publicly available information

Sophie Fawson

Health Psychology Section King's College London London UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2023 in Health Psychology Review
Verified
Journal Article
Open access
SFSophie Fawson
Sophie Fawson
ZMZoe Moon
Zoe Moon
KNKatherine Novogrudsky
Katherine Novogrudsky
FMFaye Moxham
Faye Moxham
KFKatie Forster
Katie Forster
LHLyndsay D. Hughes
Lyndsay D. Hughes
Around 42% of individuals with cancer experience distress. Acceptance and commitment therapy (ACT) can reduce distress, but effects are small, and mechanisms unclear. This review aimed to identify associations between ACT processes and distress in cancer. Search terms included cancer, ACT processes, self-compassion, and distress. Six online databases and grey literature were searched until March 2022. Of 6555 papers screened, 108 studies were included with 17,195 participants. Five meta-analyses of 77 studies were conducted. Random effects meta-analyses of correlations revealed higher scores on flexible processes (acceptance, present moment awareness, self-compassion) were associated with lower distress (rpooled = -0.24, -0.39, -0.48, respectively); whilst higher scores on inflexible processes (experiential avoidance, cognitive fusion) were associated with higher distress (rpooled = 0.58, 0.57, respectively). Meta-analyses displayed moderate-to-high heterogeneity with most studies assessed as low risk of bias. Meta-regressions revealed no significant moderators (stage, time since diagnosis, gender and age). This review provides a theoretically aligned evidence base for associations between ACT processes and distress in cancer, supporting elements of ACT theory and providing targeted directions for intervention development. Due to limited evidence, future research should focus on self-as-context, values and committed action and conduct mediation analysis in controlled trials of ACT processes on distress in cancer.

19 June 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SFSophie Fawson
Sophie Fawson
LDLesley Dibley
Lesley Dibley
KSKaylee Smith
Kaylee Smith
JBJoanna Batista
Joanna Batista
MAMicol Artom
Micol Artom
CNChristine Norton
Christine Norton

18 May 2022 in JMIR Formative Research
Verified
Journal Article
Open access
LSLouise Sweeney
Louise Sweeney
SWSula Windgassen
Sula Windgassen
MAMicol Artom
Micol Artom
CNChristine Norton
Christine Norton
SFSophie Fawson
Sophie Fawson
RMRona Moss-Morris
Rona Moss-Morris
Background: Empirical studies and systematic reviews have demonstrated the role of biological, cognitive, behavioral, and emotional factors in fatigue, pain, and urgency in inflammatory bowel disease (IBD). Behavioral management that addresses the cognitive, behavioral, and emotional factors offered alongside medical treatment is seldom available to people with IBD. Digital interventions provide a potentially scalable and cost-effective way of providing behavioral support to patients. Objective: This paper aimed to describe the process of developing a supported digital self-management intervention for fatigue, pain, and urgency in IBD using theory and evidence-based approaches and stakeholder input. Methods: The Medical Research Council framework for complex health interventions and a person-based approach were used to guide intervention development, consulting with 87 patients with IBD and 60 nurses. These frameworks informed the selection and use of a theoretical model that subsequently guided cognitive behaviorally based intervention content. They also guided the design of tailored digital intervention pathways for individuals with IBD that matched the predominant symptoms. Results: A transsymptomatic cognitive behavioral framework of symptom perpetuation was developed for the symptoms of fatigue, pain, and urgency in IBD. A logic model was used to define the intervention techniques. Patient feedback and qualitative interviews refined the website content and functionalities, including the use of visual aids, email reminders, and graphical tracking of symptoms. Nurse focus groups informed the volume and delivery model of the therapist facilitator support. Ratings of acceptability out of 10 following feasibility testing (31/87, 36%) demonstrated accessibility (scoring 9.43, SD 1.040), ease (scoring 8.07, SD 3.205), clarity, and the relevant tone of the intervention. The final intervention comprised 12 web-based sessions (8 core and 4 symptom-specific), with one 30-minute facilitator phone call following session 1 and subsequent on-site messaging. Conclusions: The use of theory and integration of stakeholders’ views throughout informed the development of an evidence-based digital intervention for fatigue, pain, and urgency in IBD. This is the first web-based self-management intervention designed to address these multiple symptoms with the aim of improving the quality of life and reducing the symptom burden of IBD. The intervention is being tested in a large multicenter randomized controlled trial. Trial Registration: ISRCTN Registry ISRCTN71618461; https://www.isrctn.com/ISRCTN71618461


18 August 2025 in British Journal of Health Psychology
Verified
Journal Article
Open access
SFSophie Fawson
Sophie Fawson
ZMZoe Moon
Zoe Moon
MRMelanie Rattue
Melanie Rattue
RMRona Moss‐Morris
Rona Moss‐Morris
LHLyndsay D. Hughes
Lyndsay D. Hughes
Objectives: Distress and physical symptoms are ongoing for early‐stage breast cancer survivors on adjuvant hormone therapy. While previous qualitative research has focused on reporting the outcomes of distress and symptoms, as well as medication adherence, this study aimed to understand the link between symptoms and distress, exploring specifically how symptoms are distressing to inform interventions. Design and Methods: A qualitative design was used with online semi‐structured interviews conducted with 23 women with Stage I–III hormone receptor positive breast cancer, living in the United Kingdom and prescribed hormone therapy in the previous 2 years, about their experience of hormone therapy. Interviews were transcribed verbatim and analysed using inductive reflexive thematic analysis. Results: The emotional burden of side‐effects was an overarching theme. Other themes depicting why symptoms are distressing included the sense of helplessness around symptoms, living with and managing difficult feelings around loss and change, living with fear, worry and uncertainty around treatment side‐effects and the internal conflict when making treatment decisions. Conclusions: The findings indicate specific areas of emotional need in women prescribed hormone therapy related to living with and managing physical symptoms. This provides insight into how symptoms can contribute to distress, which goes beyond previous research that reports the perceived consequences of symptoms and distress. The results, therefore, can inform healthcare professional communication to support and validate ongoing experiences and the underlying decision conflict, which may be distressing for some women. Furthermore, psychological interventions could address the sense of loss and acceptance of limitations and change.

19 August 2021 in JMIR Preprints
Verified
Preprint
Open access
LSLouise Sweeney
Louise Sweeney
SWSula Windgassen
Sula Windgassen
MAMicol Artom
Micol Artom
CNChristine Norton
Christine Norton
SFSophie Fawson
Sophie Fawson
RMRona Moss-Morris
Rona Moss-Morris
BACKGROUND Empirical studies and systematic reviews have demonstrated the role of biological, cognitive, behavioral, and emotional factors in fatigue, pain, and urgency in inflammatory bowel disease (IBD). Behavioral management that addresses the cognitive, behavioral, and emotional factors offered alongside medical treatment is seldom available to people with IBD. Digital interventions provide a potentially scalable and cost-effective way of providing behavioral support to patients. OBJECTIVE This paper aimed to describe the process of developing a supported digital self-management intervention for fatigue, pain, and urgency in IBD using theory and evidence-based approaches and stakeholder input. METHODS The Medical Research Council framework for complex health interventions and a person-based approach were used to guide intervention development, consulting with 87 patients with IBD and 60 nurses. These frameworks informed the selection and use of a theoretical model that subsequently guided cognitive behaviorally based intervention content. They also guided the design of tailored digital intervention pathways for individuals with IBD that matched the predominant symptoms. RESULTS A transsymptomatic cognitive behavioral framework of symptom perpetuation was developed for the symptoms of fatigue, pain, and urgency in IBD. A logic model was used to define the intervention techniques. Patient feedback and qualitative interviews refined the website content and functionalities, including the use of visual aids, email reminders, and graphical tracking of symptoms. Nurse focus groups informed the volume and delivery model of the therapist facilitator support. Ratings of acceptability out of 10 following feasibility testing (31/87, 36%) demonstrated accessibility (scoring 9.43, SD 1.040), ease (scoring 8.07, SD 3.205), clarity, and the relevant tone of the intervention. The final intervention comprised 12 web-based sessions (8 core and 4 symptom-specific), with one 30-minute facilitator phone call following session 1 and subsequent on-site messaging. CONCLUSIONS The use of theory and integration of stakeholders’ views throughout informed the development of an evidence-based digital intervention for fatigue, pain, and urgency in IBD. This is the first web-based self-management intervention designed to address these multiple symptoms with the aim of improving the quality of life and reducing the symptom burden of IBD. The intervention is being tested in a large multicenter randomized controlled trial. CLINICALTRIAL ISRCTN Registry ISRCTN71618461; https://www.isrctn.com/ISRCTN71618461